Popular joint supplement glucosamine linked to faster Alzheimer’s progression
A major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild cognitive impairment to Alzheimer’s disease. Researchers found a 25% higher likelihood of developing dementia among glucosamine users and uncovered biological
A major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild cognitive impairment to Alzheimer’s disease. Researchers found a 25% higher likelihood of developing dementia among glucosamine users and uncovered biological clues that may explain why.
This report comes from ScienceDaily. The story centres on Popular joint supplement glucosamine linked to faster Alzheimer’s progression. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from ScienceDaily and related outlets covering this beat.
